Evidence for Natural Products as Alternative Wound-Healing Therapies.
Rachael L MosesThomas A K PrescottEduard Mas-ClaretRobert SteadmanRyan MoseleyAlastair J SloanPublished in: Biomolecules (2023)
Chronic, non-healing wounds represent a significant area of unmet medical need and are a growing problem for healthcare systems around the world. They affect the quality of life for patients and are an economic burden, being difficult and time consuming to treat. They are an escalating problem across the developed world due to the increasing incidence of diabetes and the higher prevalence of ageing populations. Effective treatment options are currently lacking, and in some cases chronic wounds can persist for years. Some traditional medicines are believed to contain bioactive small molecules that induce the healing of chronic wounds by reducing excessive inflammation, thereby allowing re-epithelisation to occur. Furthermore, many small molecules found in plants are known to have antibacterial properties and, although they lack the therapeutic selectivity of antibiotics, they are certainly capable of acting as topical antiseptics when applied to infected wounds. As these molecules act through mechanisms of action distinct from those of clinically used antibiotics, they are often active against antibiotic resistant bacteria. Although there are numerous studies highlighting the effects of naturally occurring small molecules in wound-healing assays in vitro, only evidence from well conducted clinical trials can allow these molecules or the remedies that contain them to progress to the clinic. With this in mind, we review wound-healing natural remedies that have entered clinical trials over a twenty-year period to the present. We examine the bioactive small molecules likely to be in involved and, where possible, their mechanisms of action.
Keyphrases
- wound healing
- clinical trial
- healthcare
- risk factors
- end stage renal disease
- type diabetes
- newly diagnosed
- ejection fraction
- oxidative stress
- cardiovascular disease
- peritoneal dialysis
- randomized controlled trial
- phase ii
- metabolic syndrome
- physical activity
- prognostic factors
- skeletal muscle
- open label
- study protocol
- glycemic control
- body mass index
- silver nanoparticles
- case control